Digital Inmed

PCD Pharma Franchise

365 Health

Panchkula, Haryana India

About Me

Welcome to InMed Therapeutics India, One of The Best PCD Pharma Franchise Company in India. Inmed Therap is the Haryana based pharmaceutical company that manufacture the high-quality pharma drugs and medicines for the healthcare sector. Here we combine the strength of technology and the experience and qualification of experts to manufacture the supreme quality drugs. Inmed Therap is ISO 9001:2015 certified Pharmaceutical company with state-of-art manufacturing facilities. Our Product portfolio included the Tablets, Capsules, Injections, Softgel, Sachet, Ointment etc. So we are the top pharmaceutical company that is offering the monopoly-based top Pharma Franchise, PCD Franchise in all India.

Interested in solutions for:

For my company

I am looking for healthcare innovations:

You have not backed any projects. Lets change that!
Discover Projects

No project created yet. Lets change that!
Discover Projects

No comments on any project yet. Lets change that!
Discover Projects

No likes on any project yet.. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No project reviewed yet. Lets change that!
Discover Projects

Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.